medigraphic.com
ISSN 0016-3813 (Print)

2016, Number S2

Next >>

Gac Med Mex 2016; 152 (S2)

Purification of Salmonella Typhimurium OmpD Porin Induces Long-Term High Levels of Antibodies: Implications on the Development of Vaccines against Non-Typhoid Salmonella

Pérez-Toledo M, Martínez-Amador PA, Pastelin-Palacios R, Isibasi A, Cunningham AF, López-Macías C

Language: Spanish
References: 22
Page: 5-13
PDF size: 168.76 Kb.


ABSTRACT

In the present work, we report, for the first time, on the purification of the Salmonella Typhimurium OmpD porin. We assessed the integrity and purity of the protein and evaluated the immunogenicity of the protein and its ability to induce antibody without exogenous adjuvant. We observed that 10 μg OmpD induced high antibody levels of IgM and IgG, which were maintained for more than 260 days after immunization. Immunization with OmpD induced multiple IgG antibody isotypes including IgG1, IgG2a, IgG2b, and IgG3 subclasses. Furthermore, these antibodies were able to recognize and bind to the bacterial surface. Our results demonstrate the high immunogenicity of S. Typhimurium OmpD porin, which induces long-lasting antibodies which may be and important target of the immune response against Salmonella infection. In conclusion, we propose the OmpD porin could be used within novel subunit vaccine formulations that do not need additional adjuvant and that confer long lasting humoral immunity against Salmonella infections.


REFERENCES

  1. Swearingen MC, Porwollik S, Desai PT, McClelland M, Ahmer BM. Virulence of 32 Salmonella strains in mice. PLoS One. 2012;7:e36043.

  2. Calva E. SalmonellaTyphiy la fiebre tifoidea: de la biología molecular a la salud pública. En: Martínez Romero E, Martínez Romero JC, editores. Microbios en línea. Instituto de Bioltecnología, UNAM; 2002.

  3. Morpeth SC, Ramadhani HO, Crump JA. Invasive non-typhi Salmonella disease in Africa. Clin Infect Dis. 2009;49:606-11.

  4. Feasey NA, Dougan G, Kingsley RA, Heyderman RS, Gordon MA. Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa. Lancet. 2012;379:2489-99.

  5. Zaidi MB, Macias CL, Calva E. [Mexican studies on Salmonella: epidemiology, vaccines and molecular biology]. Rev Latinoam Microbiol. 2006;48:121-5.

  6. Kodama C, Matsui H. Salmonella flagellin is not a dominant protective antigen in oral immunization with attenuated live vaccine strains. Infect Immun. 2004;72:2449-51.

  7. Bobat S, Flores-Langarica A, Hitchcock J, et al. Soluble flagellin, FliC, induces an Ag-specific Th2 response, yet promotes T-bet-regulated Th1 clearance of Salmonella Typhimurium infection. Eur J Immunol. 2011;41:1606-18.

  8. Svenson SB, Lindberg AA. Artificial Salmonella vaccines: Salmonella Typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit protective antibodies in rabbits and mice. Infect Immun. 1981;32:490-6.

  9. Tamm LK, Arora A, Kleinschmidt JH. Structure and assembly of beta- barrel membrane proteins. J Biol Chem. 2001;276:32399-402.

  10. Frohlich KS, Papenfort K, Berger AA, Vogel J. A conserved RpoS-dependent small RNA controls the synthesis of major porin OmpD. Nucleic Acids Res. 2012;40:3623-40.

  11. Meyer PN, Wilmes-Riesenberg MR, Stathopoulos C, Curtiss R, 3rd. Virulence of a Salmonella Typhimurium OmpD mutant. Infect Immun. 1998;66:387-90.

  12. Gil-Cruz C, Bobat S, Marshall JL, et al. The porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody response. Proc Natl Acad Sci U S A. 2009;106:9803-8.

  13. MacLennan CA, Gilchrist JJ, Gordon MA, et al. Dysregulated humoral immunity to nontyphoidal Salmonella in HIV-infected African adults. Science. 2010;328:508-12.

  14. Nikaido H. Proteins forming large channels from bacterial and mitochondrial outer membranes: porins and phage lambda receptor protein. Methods Enzymol. 1983;97:85-100.

  15. Salazar-Gonzalez RM, Maldonado-Bernal C, Ramirez-Cruz NE, et al. Induction of cellular immune response and anti-Salmonella enterica serovarTyphibactericidal antibodies in healthy volunteers by immunization with a vaccine candidate against typhoid fever. Immunol Lett. 2004;93:115-22.

  16. Bentley AT, Klebba PE. Effect of lipopolysaccharide structure on reactivity of antiporin monoclonal antibodies with the bacterial cell surface. J Bacteriol. 1988;170:1063-8.

  17. Secundino I, Lopez-Macias C, Cervantes-Barragan L, et al. Salmonella porins induce a sustained, lifelong specific bactericidal antibody memory response. Immunology. 2006;117:59-70.

  18. Santiviago CA, Toro CS, Hidalgo AA, Youderian P, Mora GC. Global regulation of the Salmonella enterica serovar Typhimurium major porin, OmpD. J Bacteriol. 2003;185:5901-5.

  19. Gavin AL, Barnes N, Dijstelbloem HM, Hogarth PM. Identification of the mouse IgG3 receptor: implications for antibody effector function at the interface between innate and adaptive immunity. J Immunol. 1998;160:20-3.

  20. Hazenbos WL, Heijnen IA, Meyer D, et al. Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16). J Immunol. 1998;161:3026-32.

  21. Biburger M, Aschermann S, Schwab I, et al. Monocyte subsets responsible for immunoglobulin G-dependent effector functions in vivo. Immunity. 2011;35:932-44.

  22. Siggins MK, Cunningham AF, Marshall JL, Chamberlain JL, Henderson IR, MacLennan CA. Absent bactericidal activity of mouse serum against invasive African nontyphoidal Salmonella results from impaired complement function but not a lack of antibody. J Immunol. 2011;186:2365-71.




2020     |     www.medigraphic.com